Franklin Resources
RPRX

Franklin Resources’s Repros Therapeutics Inc. RPRX Stock Holding History

Franklin Resources’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,611,325
Closed -$45.2M – 1632
2014
Q2 		$45.2M Buy
2,611,325
+260,100
+11% +$4.24M 0.02% 635
2014
Q1 		$41.7M Buy
2,351,225
+817,200
+53% +$15.8M 0.02% 646
2013
Q4 		$28.1M Buy
1,534,025
+215,225
+16% +$4.06M 0.01% 715
2013
Q3 		$35.3M Buy
1,318,800
+254,800
+24% +$5.46M 0.02% 647
2013
Q2 		$19.6M Buy
+1,064,000
New +$18.8M 0.01% 760

Other funds holding RPRX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DCM
Destrier Capital Management New York $144M AUM 7.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Franklin Resources's RPRX Position: Q3 2014 in Review

Franklin Resources sold out of Repros Therapeutics Inc. (RPRX) in Q3 2014, closing a stake of 2,611,325 shares — an estimated $45.2M sold.

Franklin Resources first reported a position in RPRX in Q2 2013 and held it in 5 quarters. The position peaked at $45.2M in Q2 2014. 75 funds tracked by Wall St. Rank hold RPRX as of Q3 2014.

  • Franklin Resources reported no remaining Repros Therapeutics Inc. position as of Q3 2014 after selling out during the quarter.
  • Franklin Resources sold 2,611,325 Repros Therapeutics Inc. shares in Q3 2014, an estimated $45.2M.
  • Franklin Resources first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 5 quarters.
  • Franklin Resources's Repros Therapeutics Inc. position peaked at $45.2M in Q2 2014.
  • 75 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q3 2014.

Based on Franklin Resources's 13F filing for Q3 2014, filed 12 Nov 2014.